Fig. 3: Relative levels of various combinations of biomarkers in the stools of NEC infants for distinct periods preceding diagnosis. | Pediatric Research

Fig. 3: Relative levels of various combinations of biomarkers in the stools of NEC infants for distinct periods preceding diagnosis.

From: Lipocalin-2 and calprotectin as stool biomarkers for predicting necrotizing enterocolitis in premature neonates

Fig. 3

For each NEC infant, the stool samples were pooled for three periods relative to the diagnosis: group A, −10 to −7 days; group B, −6 to −3 days; and group C, −2 to 0 days while non-NEC samples (NN) were pooled for the 10-day period and the data for combining the biomarkers were processed as indicated. The means ± SEM are illustrated. *P < 0.05 (#P < 0.07) using the Wilcoxon matched pairs signed-rank test by comparison with NN.

Back to article page